Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings

BACKGROUND: Peripheral diagnostics for Alzheimer’s disease (AD) continue to be developed. Diagnostics capable of detecting AD before the onset of symptoms are particularly desirable, and, given the fact that early detection is imperative for alleviating long-term symptoms of the disease, methods whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbagh, Marwan N, Shi, Jiong, Lee, Moonhee, Arnold, Lisa, Al-Hasan, Yazan, Heim, Jennifer, McGeer, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158897/
https://www.ncbi.nlm.nih.gov/pubmed/30257642
http://dx.doi.org/10.1186/s12883-018-1160-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158897/
https://www.ncbi.nlm.nih.gov/pubmed/30257642
http://dx.doi.org/10.1186/s12883-018-1160-y

Ejemplares similares